Nasus Pharma Ltd.

NSRXAMEXHealthcare● Active

$3.00

+$0.09(+3.09%)

Market Cap$25837857

P/E Ratio—

52W High$9.99

52W Low$1.98

Avg Volume215K

Open$2.90

Beta4.29

Overview

Nasus Pharma Ltd. (NSRX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

nsrx · stock forecast · 1 analysts (3M) · FMP · updated Mar 26, 2026

Analyst Rating & Consensus

Based on 1 Wall Street analysts in the past 3 months

Buy

1 analysts

consensus

Rating Breakdown

Strong Buy

Buy

Hold

Sell

Strong Sell

Total: 1 · Buy rate: 100.0%

12-Month Price Target

High

$22.00

Consensus

$22.00

+633.4% upside

Low

$22.00

Median: $22 · Last Close: $3.00

The Nasus Pharma Ltd. (NSRX) analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month NSRX price target is $22.00, representing +633.4% upside from the current price of $3.00.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Analyst price target coverage is insufficient to generate a forecast chart for this stock.

Short-Term Price Prediction

Algorithmically generated · Updated daily

Date	Predicted Price	Change	Min	Max
2026-06-10	$3.02	↑ 0.68%	$2.99	$3.05

1-day model range: $2.99–$3.05. Peak: $3.05 (+0.68%).

Long-Term Stock Price Prediction

⚠️ Long-term projections are hidden until 252 trading days of history (IPO / limited listing). Short-term tab may still show model output.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%

2Buy

1Neutral

11Sell

RSI (14)59.3Neutral

MACDBULLISH

Refreshes daily from EOD close

Moving Averages · NSRX · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$3.04SELL

MA 10$3.14SELL

MA 20$3.00SELL

MA 50$2.82BUY

MA 100$3.88SELL

MA 200$5.68SELL

Current $NSRX · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$3.03SELL

EMA 10$3.05SELL

EMA 20$3.03SELL

EMA 50$3.17SELL

EMA 100$3.91SELL

EMA 200$5.68SELL

Current $NSRX · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:

Date	Brokerage	Action	Rating
2026-03-26	Citizens	Maintains	Market Outperform→Market Outperform

Citizens2026-03-26

Maintains

Market Outperform→Market Outperform

Wall Street analysts have recently issued updated ratings on Nasus Pharma Ltd. (NSRX) stock. Of the recent 1 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover NSRX.

Analyst Recommendation Trends

Buy ratings1 → 1

Hold ratings0 → 0

Sell ratings0 → 0

NSRX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

—

Revenue Next Year

—

EPS This Year

—

EPS Next Year

—

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NSRX EPS of $— for the current fiscal year, based on estimates from 0 analysts. The NSRX revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The NSRX stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NSRX price target is $22.00 (+633.4% upside), with an analyst consensus of Buy.

The NSRX short-term stock prediction for tomorrow is $3.02 (+0.68%).

Nasus Pharma Ltd. trades on AMEX under the ticker NSRX. The NSRX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Earnings Revenue PE Ratio Financials Market Cap Insider Trades Dividends Price History

Frequently asked questions

NSRX forecast · 8 questions

According to 1 Wall Street analysts, the average 12-month NSRX price target is $22.00, with a high forecast of $22.00 and a low of $22.00. The median price target is shown in the chart above when available. This implies +633.4% potential upside from the current price of $3.00.

NSRX price targetWhat is NSRX price targetNSRX analyst price targetNSRX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.